Top View
- Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
- Action of Dilazep Dihydrochloride on Chemiluminescence from a Xanthine Oxidase/Acetaldehyde System
- (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
- Stembook 2018.Pdf
- Adenosine Receptor Agonists Deepen the Inhibition of Platelet Aggregation
- (12) United States Patent (10) Patent No.: US 6,989,376 B2 Watkins Et Al
- Infrared Reference Spectra
- Pharmaceuticals Appendix
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- Active Adenosine Transporter-Mediated Adenosine Entrance Into HL-60 Cells Leads to the Induction of Apoptosis Through Down-Regulation of C-Myc
- Therapeutic Endoscopy-Related GI Bleeding and Thromboembolic
- FAST TOXICOLOGICAL SCREENING KIT by LC-MS/MS – Code SC9005B
- Effects of a Nucleoside Transporter Inhibitor, Dilazep, on Renal Microcirculation in Rats
- The University of Chicago Microbially-Regulated
- And Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells
- MAVENCLAD (Cladribine) Tablets, for Oral Use HIV Infection
- Rational Drug Design for Neglected Diseases: Implementation of Computational Methods to Construct Predictive Devices and Examine Mechanisms
- Targeting the Equilibrative Nucleoside Transporter ENT1 in Huntington Disease
- Mavenclad, INN-Cladribine
- MAVENCLAD Tablets Are Uncoated, Other Side Effects Not Listed Above White, Round, Biconvex Tablets May Also Occur in Some People
- Changes in Nucleoside Transport of HL-60 Human Promyelocytic Cells During Tvjaf-Dimethylformamide Induced Differentiation1
- Customs Tariff - Schedule Xxi - 1
- Dilazep and Dipyridamole Inhibit Tissue Factor Expression on Monocytes Induced by Igg from Patients with Antiphospholipid Syndrome1
- Nitrobenzylthioinosine-Sensitive and -Insensitive Influx Karen L
- Identification of the ENT1 Antagonists Dipyridamole and Dilazep As Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
- A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Anatomical Distribution of Nucleoside System in the Human Brain and Implications for Therapy
- International Patent Classification: TR), OAPI (BF, BJ, CF, CG, Cl, CM, GA, GN, GQ, GW, A61K 31/4439 (2006.01) A61K 31/519 (2006.01) KM, ML, MR, NE, SN, TD, TG)
- A Study on Dilazep: I. Mechanism of Anti-Ischemic Action of Dilazep Is
- Long-Term Effect of Imidapril Hydrochloride Compared With
- ICD-10-CM TABLE of DRUGS and CHEMICALS
- Pharmaceutical Appendix to the Tariff Schedule 2
- Functional Nucleoside Transporters Are Required for Gemcitabine Influx and Manifestation of Toxicity in Cancer Cell Lines1
- The Modulation of Non-Steroidal Anti-Inflammatory Toxicity As a Function of The
- Download Product Insert (PDF)
- Supplementary Material
- ICD-10-CM Drug FY2021
- Reduction of MMP-9 and MIF Levels Is Associated with the Beneficial
- Package Leaflet: Information for the User MAVENCLAD 10 Mg Tablets
- Sonoporation: Applications for Cancer Therapy 15
- Effect of the Antiplatelet Drug Dilazep Dihydrochloride on Urinary Podocytes in Patients in the Early Stage of Diabetic Nephropathy
- Nucleoside Anticancer Drugs: the Role of Nucleoside Transporters in Resistance to Cancer Chemotherapyw
- ICD-10-CM Table of Drugs 2019
- (19) United States (12) Patent Application Publication (10) Pub
- Characterization of Nitrobenzylthioinosine Binding to Nucleoside Transport Sites Selective for Adenosine in Rat Brain’
- Nucleoside Salvage and Resistance to Antimetabolite Anticancer Agents M
- A Comparisonof the Abilitiesof Nitrobenzylthioinosine,Dilazep,And
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis